v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive (Loss) Income, net
Beginning Balance at Dec. 31, 2024 $ 327,788 $ 322,791 $ 29,687 $ 17,772 $ (42,462)
Beginning Balance, Shares at Dec. 31, 2024   84,972,610      
Net (loss) income 862     862  
Other comprehensive income (loss) 3,772       3,772
Exercises of warrants to purchase common stock 9,445 $ 9,445      
Exercises of warrants to purchase common stock, Shares   3,778,000      
Restricted stock award grants and related compensation expense 2,501 $ 2,501      
Restricted stock award grants and related compensation expense, Shares   3,496,322      
Restricted stock award forfeitures and cancellations (103) $ (103)      
Restricted stock award forfeitures and cancellations, Shares   (72,402)      
Ending Balance at Jun. 30, 2025 344,265 $ 334,634 29,687 18,634 (38,690)
Ending Balance, Shares at Jun. 30, 2025   92,174,530      
Beginning Balance at Mar. 31, 2025 338,289 $ 329,920 29,687 17,338 (38,656)
Beginning Balance, Shares at Mar. 31, 2025   87,777,849      
Net (loss) income 1,296     1,296  
Other comprehensive income (loss) (34)       (34)
Exercises of warrants to purchase common stock 2,540 $ 2,540      
Exercises of warrants to purchase common stock, Shares   1,016,000      
Restricted stock award grants and related compensation expense 2,225 $ 2,225      
Restricted stock award grants and related compensation expense, Shares   3,400,000      
Restricted stock award forfeitures and cancellations (51) $ (51)      
Restricted stock award forfeitures and cancellations, Shares   (19,319)      
Ending Balance at Jun. 30, 2025 344,265 $ 334,634 29,687 18,634 (38,690)
Ending Balance, Shares at Jun. 30, 2025   92,174,530      
Beginning Balance at Dec. 31, 2025 323,691 [1] $ 331,917 23,552 (659) (31,119)
Beginning Balance, Shares at Dec. 31, 2025   91,475,278      
Net (loss) income (459)     (459)  
Other comprehensive income (loss) (790)       (790)
Dividends on common stock (47,617)     (47,617)  
Exercises of warrants to purchase common stock 337 $ 337      
Exercises of warrants to purchase common stock, Shares   204,000      
Restricted stock award grants and related compensation expense 612 $ 612      
Restricted stock award grants and related compensation expense, Shares   699,779      
Restricted stock award forfeitures and cancellations (377) $ (377)      
Restricted stock award forfeitures and cancellations, Shares   (2,723,846)      
Ending Balance at Jun. 30, 2026 275,397 $ 332,489 23,552 (48,735) (31,909)
Ending Balance, Shares at Jun. 30, 2026   89,655,211      
Beginning Balance at Mar. 31, 2026 276,964 $ 332,152 23,552 (47,440) (31,300)
Beginning Balance, Shares at Mar. 31, 2026   89,796,993      
Net (loss) income (1,295)     (1,295)  
Other comprehensive income (loss) (609)       (609)
Exercises of warrants to purchase common stock 337 $ 337      
Exercises of warrants to purchase common stock, Shares   204,000      
Restricted stock award grants and related compensation expense 340 $ 340      
Restricted stock award grants and related compensation expense, Shares   4,950      
Restricted stock award forfeitures and cancellations (340) $ (340)      
Restricted stock award forfeitures and cancellations, Shares   (350,732)      
Ending Balance at Jun. 30, 2026 $ 275,397 $ 332,489 $ 23,552 $ (48,735) $ (31,909)
Ending Balance, Shares at Jun. 30, 2026   89,655,211      
[1] Derived from audited December 31, 2025 Consolidated Financial Statements.